These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6410896)

  • 1. The effect of iron-deficiency anemia on cytolytic activity of mice spleen and peritoneal cells against allogenic tumor cells.
    Kuvibidila SR; Baliga BS; Suskind RM
    Am J Clin Nutr; 1983 Aug; 38(2):238-44. PubMed ID: 6410896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
    Jones B; Jones TC
    Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage cytotoxicity in the mouse immune response against a skin allograft.
    Dimitriu A; Dy M; Thomson N; Hamburger J
    J Immunol; 1975 Jan; 114(1 Pt 1):195-9. PubMed ID: 122985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of humoral factors of the mastocytoma P815 cells on the formation of allospecific killers in mixed culture of lymphocytes and their cytotoxic activity].
    Medvedev AE; Dostman U; Flegel' A
    Biull Eksp Biol Med; 1989 Aug; 108(8):224-6. PubMed ID: 2529921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
    Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
    Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of blastogenic response of splenic lymphocytes from iron-deficient mice: in vivo repletion.
    Kuvibidila S; Nauss KM; Baliga BS; Suskind RM
    Am J Clin Nutr; 1983 Jan; 37(1):15-25. PubMed ID: 6600368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of a subpopulation of T cells bearing histamine receptors.
    Plaut M; Lichtenstein LM; Henney CS
    J Clin Invest; 1975 Apr; 55(4):856-74. PubMed ID: 164483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells].
    Medvedev AE; Fuks BB
    Biull Eksp Biol Med; 1989 Aug; 108(8):194-6. PubMed ID: 2508789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES
    J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative studies of the growth and rejection of allogeneic tumour cells in mouse cerebrospinal fluid. Elimination in the absence of H-2 differences.
    Doherty PC; Zinkernagel RM
    Clin Exp Immunol; 1975 Feb; 19(2):355-66. PubMed ID: 813923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect by cooperation of splenic and peritoneal adherent cells on generation of cytotoxic T lymphocytes.
    Koga Y; Taniguchi K; Kubo C; Nomoto K
    Microbiol Immunol; 1982; 26(8):723-31. PubMed ID: 6217406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of macrophage-mediated cytotoxicity.
    Ziegler FG; Lohmann-Matthes ML; Fischer H
    Int Arch Allergy Appl Immunol; 1975; 48(2):182-91. PubMed ID: 803933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytolytic and cytostatic anti-tumor activities of macrophages from mice injected with murine sarcoma virus.
    Puccetti P; Holden HT
    Int J Cancer; 1979 Jan; 23(1):123-32. PubMed ID: 759378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.